Drug
Benzoyl Peroxide Clindamycin
Benzoyl Peroxide Clindamycin: highest development phase Post-Market, developed by GlaxoSmithKline. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| BENZOYL PEROXIDE/ CLINDAMYCIN NCT00887484 | Post-Market | Acne Vulgaris |
Latest
No recent events.
Follow Benzoyl Peroxide Clindamycin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.